Literature DB >> 21731906

General aspects of the treatment of alcoholic hepatitis.

Michael J Babineaux1, Bhupinderjit S Anand.   

Abstract

General measures for treating patients with alcoholic hepatitis (AH) are similar irrespective of the disease severity. Alcohol abstinence is the cornerstone of treatment and can be achieved with appropriate social support, Alcoholics Anonymous and sometimes pharmacological therapy. Alcohol withdrawal should be anticipated and treatment initiated to prevent this complication. Treatment for complications of cirrhosis should be as for any other patient with cirrhosis. AH patients are particularly prone to infections and malnutrition. These should be identified and treated appropriately using broad spectrum antibiotics and nutritional support respectively.

Entities:  

Keywords:  Alcohol abstinence; Alcohol withdrawal; Alcoholic hepatitis; Complications of cirrhosis; Malnutrition; Nutritional support; Treatment

Year:  2011        PMID: 21731906      PMCID: PMC3124880          DOI: 10.4254/wjh.v3.i5.125

Source DB:  PubMed          Journal:  World J Hepatol


  34 in total

1.  Endoscopic treatment versus endoscopic plus pharmacologic treatment for acute variceal bleeding: a meta-analysis.

Authors:  Rafael Bañares; Agustín Albillos; Diego Rincón; Sonia Alonso; Mónica González; Luis Ruiz-del-Arbol; Magdalena Salcedo; Luis-Miguel Molinero
Journal:  Hepatology       Date:  2002-03       Impact factor: 17.425

Review 2.  Nutritional aspects of alcoholic liver disease.

Authors:  Carroll M Leevy; Serban A Moroianu
Journal:  Clin Liver Dis       Date:  2005-02       Impact factor: 6.126

Review 3.  Diagnosis, course, and assessment of alcohol abuse and dependence in adolescents.

Authors:  Tammy Chung; Christopher S Martin; Ken C Winters
Journal:  Recent Dev Alcohol       Date:  2005

4.  Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis.

Authors:  P Sort; M Navasa; V Arroyo; X Aldeguer; R Planas; L Ruiz-del-Arbol; L Castells; V Vargas; G Soriano; M Guevara; P Ginès; J Rodés
Journal:  N Engl J Med       Date:  1999-08-05       Impact factor: 91.245

5.  Hospital experience and outcomes for esophageal variceal bleeding.

Authors:  Sydney Morss Dy; David M Cromwell; Paul J Thuluvath; Eric B Bass
Journal:  Int J Qual Health Care       Date:  2003-04       Impact factor: 2.038

6.  MELD score is better than Child-Pugh score in predicting 3-month survival of patients undergoing transjugular intrahepatic portosystemic shunt.

Authors:  Francesco Salerno; Manuela Merli; Massimo Cazzaniga; Valentina Valeriano; Plinio Rossi; Andrea Lovaria; Daniele Meregaglia; Antonio Nicolini; Lorenzo Lubatti; Oliviero Riggio
Journal:  J Hepatol       Date:  2002-04       Impact factor: 25.083

7.  Five-year survival predictive factors in patients with excessive alcohol intake and cirrhosis. Effect of alcoholic hepatitis, smoking and abstinence.

Authors:  F Pessione; M J Ramond; L Peters; B N Pham; P Batel; B Rueff; D C Valla
Journal:  Liver Int       Date:  2003-02       Impact factor: 5.828

8.  Outcome analysis of cirrhotic patients undergoing chest tube placement.

Authors:  Lawrence U Liu; Hassan A Haddadin; Carol A Bodian; Samuel H Sigal; Jessica D Korman; Henry C Bodenheimer; Thomas D Schiano
Journal:  Chest       Date:  2004-07       Impact factor: 9.410

9.  The value of the CAGE in screening for alcohol abuse and alcohol dependence in general clinical populations: a diagnostic meta-analysis.

Authors:  B Aertgeerts; F Buntinx; A Kester
Journal:  J Clin Epidemiol       Date:  2004-01       Impact factor: 6.437

10.  Octreotide in the control of post-sclerotherapy bleeding from oesophageal varices, ulcers and oesophagitis.

Authors:  S A Jenkins; A N Kingsnorth; S Ellenbogen; G Copeland; N Davies; R Sutton; R Shields
Journal:  HPB Surg       Date:  1996
View more
  3 in total

Review 1.  Grand Rounds: Alcoholic Hepatitis.

Authors:  Ashwani K Singal; Alexandre Louvet; Vijay H Shah; Patrick S Kamath
Journal:  J Hepatol       Date:  2018-06-13       Impact factor: 25.083

2.  Nutritional status of patients with alcoholic cirrhosis undergoing liver transplantation: time trends and impact on survival.

Authors:  Ashwani K Singal; Patrick S Kamath; Nickie Francisco Ziller; Sara DiCecco; M Shoreibah; Walter Kremers; Michael R Charlton; Julie K Heimbach; Kymberly D Watt; Vijay H Shah
Journal:  Transpl Int       Date:  2013-06-11       Impact factor: 3.782

Review 3.  Current Status of Herbal Medicines in Chronic Liver Disease Therapy: The Biological Effects, Molecular Targets and Future Prospects.

Authors:  Ming Hong; Sha Li; Hor Yue Tan; Ning Wang; Sai-Wah Tsao; Yibin Feng
Journal:  Int J Mol Sci       Date:  2015-12-02       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.